A novel non-ionic surfactant nanoemulsion designated 8N8 has been tested for its biocidal activity. One percent 8N8 produced effective bactericidal activity against Bacillus cereus, Bacillus subtilis, Haemophilus influenzae, Neisseria gonorrhoeae, Streptococcus pneumoniae, and Vibrio cholerae in 15 minutes. In contrast, most enteric Gram-negative bacteria were resistant to 8N8. One percent 8N8 was also virucidal within 15 minutes for all tested enveloped viruses, including Herpes simplex type 1, influenza A and vaccinia viruses. One percent 8N8 also demonstrated fungistatic activity on Candida albicans. The rapid and non-specific inactivation of vegetative bacteria and enveloped viruses, in addition to its fungistatic activity and low toxicity in experimental animals, makes 8N8 a potential candidate for use as a topical biocidal agent.
Introduction
The search for effective topical biocidal therapeutics has always been challenging due to ability of pathogenic microorganisms to continually evade such agents (Devlin 1998 ; Eady and Cove 1990 ; Harkaway et al. 1992 ; Hennessy 1994) . Most medicines for the treatment of infections of the skin or mucous membranes contain antibiotics or chemotherapeutics that inhibit crucial microbial biochemical pathways. Empirical or indiscriminate use of these agents results in the emergence of resistant pathogens (File 1999 ; Gonzales and Sande 1995 ; Okeke et al. 1999 ; Rao 1998) , and requires the ongoing development of new anti-microbial therapeutics. Given this, any non-toxic agent that has the ability to rapidly kill a broad spectrum of microbial pathogens could be of great value. Unfortunately, many such therapeutics are not suitable for topical treatment because of their toxicity (Lineaweaver et al. 1985; Rutala and Weber 1997) . Aldehydes and phenols are used as surface disinfectants rather than topical antiseptics due to their high toxicity (McDonnell and Russell 1999) . Quaternary ammonium compounds have a limited application due to their low efficacy against fungi, staphylococci, and Gram-negative bacteria (BundgaardNielsen and Nielsen 1996 ; Heir et al. 1999 ; McDonnell and Russell 1999) . In spite of its broad-spectrum efficacy and low irritation, chlorhexidine activity is pH dependent and is greatly reduced in the presence of organic matter (Russell and Day 1993) . Thus, there is an ongoing need for the development of safe anti-microbial formulations with broad range and rapid biocidal activity.
Antimicrobial nanoemulsions are novel water-in-oil formulations that are stabilized by the addition of small amounts of surfactants . The waterimmiscible liquid phase is mixed into an aqueous phase by high stress mechanical extrusion, yielding a uniform population of droplets ranging in diameter from 400 -800 nm. The structure of the nanoemulsion plays a vital role in its function (Florence 1993 ; Gregoriadis and Florence 1993 ; Wasan and Lopez-Berestein 1995) . The discrete droplets of oil selectively fuse with bacterial cell walls or viral envelopes destabilizing the organism's lipid envelope and initiate disruption of pathogens . In previous papers, we reported that surfactant nanoemulsion had a strong sporicidal activity on Bacillus species spores (Hamouda et al. 1999) and that they could be used for the prevention of murine influenza A virus pneumonitis (Donovan et al. 2000) . The aim of this study was to examine the biocidal efficacy of one surfactant nanoemulsion, designated 8N8, on bacteria, viruses and fungi.
Materials and methods
8N8 nanoemulsion. 8N8 was prepared as described previously (Hamouda et al. 1999) . Briefly, an oil phase was made by mixing 8 volumes tributyl phosphate, 64 volumes soybean oil, and 8 volumes Triton X-100, and heating it at 82°C for one hour. It was then mixed with 20 volumes of deionized water (diH 2 O) with a reciprocating syringe pump Florence 1993 ). The final particle size of the nanoemulsion was in the range of 400 -800 nm as measured using a laser light scatter (LS230; Coulter, Hialeah, FL). Bactericidal assay. Bacteria were grown on the appropriate solid medium overnight prior to testing. A few colonies were suspended into BHI broth so that the bacterial count was approximately 1.5 × 10 8 colony forming units per ml (CFU/ml), based on the 0.5 McFarland standard for bactericidal testing (Hendrichson and Krenz 1991) . Equal volumes of bacterial suspension were mixed with variable concentrations of 8N8 diluted in diH 2 O and incubated at 37°C for 15 minutes on a tube rotator. Ten-fold serial dilutions were made and duplicate aliquots were plated on solid media. After overnight incubation, colonies were counted. Bactericidal activity was calculated as the log reduction in bacterial count after treatment: Log 10 (Initial CFU) -Log 10 (post-treatment CFU). All bactericidal assays were repeated at least three times and average results were reported.
Microorganisms
Virucidal assay. To assess the virucidal activity of 8N8 on the vaccinia, Herpes simplex and influenza A viruses, the plaque reduction assay (PRA) was performed on either VERO (African green monkey kidney -ATCC CCL 81) cells (for the vaccinia and Herpes simplex viruses) or MDCK (Madin Darby Canine Kidney -ATCC CCL-34) cells (for the influenza A virus). Both cell lines were grown in Eagle's minimal essential medium (MEM) with Earle's salts, 2mM L-glutamine, and 1.5 g /l sodium bicarbonate and supplemented with 10% fetal bovine serum (FBS). 8N8 diluted in infection medium (the cell growth medium without the FBS) was mixed with an equal volume of the virus (approx. 10 6 plaque forming units (pfu)/ml) and incubated at 37°C for variable time intervals. After treatment, the virus was diluted in the infection medium and overlaid on the cells. Infected cells were incubated at 37°C in 5% CO 2 for 1 hour (vaccinia virus and influenza A virus) or for 2 hours (Herpes simplex virus), then the infection medium was replaced with cell growth medium and the cells were incubated for an additional 48 h. Plaques were made visible by staining with 2% Coomassie blue in 50% methanol and 5% glacial acetic acid (Vaccinia virus) or with 0.1% w/v Crystal Violet in 20% methanol (Herpes simplex virus) or with agarose overlay medium (2 × infection medium with 1.6% SeaKem agarose and 3 µg /ml TPCK-treated trypsin) containing 0.01% neutral red (influenza A virus).
Recombinant adenovirus (Ad RSV nt lacZ) was used to test 8N8's virucidal activity against non-enveloped virus utilizing the β-galactosidase assay as described previously (Lim and Chae, 1989) . Briefly, 293 cells were seeded in "U"-bottom 96-well tissue culture plates in Dulbecco's modified Eagle medium (DMEM) supplemented with 4.5 g/l glucose, 2 mM L-glutamine and 10% FBS. Various concentrations of 8N8 diluted in serum-free medium were mixed with an equal volume of adenovirus (approx. 5 ×10 7 pfu /ml) and incubated at 37°C for 30 minutes. After treatment, the virus was diluted in infection medium and overlaid on the cells, and the plates were incubated at 37°C in 5% CO 2 overnight. The cells were then washed, fresh medium was added, and the plates were incubated for an additional 5 days. Cell lysates were tested using the β-galactosidase enzyme assay system (Promega, Madison, WI).
PRA and β-galactosidase enzyme assays were performed in triplicate, and the virucidal activity was calculated as described for bactericidal activity.
Fungistatic activity assay. Candida albicans was grown in 5 ml BHI medium at 37°C overnight. Cells were then washed, re-suspended in 10 ml diH 2 O, and counted using a hemocytometer. Two ml of BHI medium containing 1×10 6 CFU/ml were mixed with equal volumes of different concentrations of 8N8 or with the diH 2 O control and incubated for 24 hours. The mixtures were diluted and aliquots were plated in duplicate on Sabouraud dextrose agar. After overnight incubation, the colonies were counted, and the fungistatic effect was calculated :
1-# of treated cells-initial # of cells ×100.
# of untreated cells-initial # of cells

Electron microscopy (EM).
The influenza A virus was semi-purified from the allantoic fluid by passing it through a 30% sucrose cushion prepared with GTNE (glycine 200 mM, Tris-HCl 10 mM pH 8.8, NaCl 100mM and EDTA 1mM) using ultracentrifugation (Beckman rotor SW 28 Ti at 20,000 rpm for 16 hours). The influenza A and adenovirus were then treated with 1% 8N8 for 15 and 60 minutes, respectively. The treated and untreated viruses were placed on parlodian-coated 200-mesh copper grids for 2 minutes, then fixed with 2% glutaraldehyde in 0.1 M cacodylate buffer. The grids were prepared for routine transmission electron microscopy and stained with 7% uranyl acetate for 30 seconds. The grids were examined with a Philips EM400T transmission electron microscope (Accelerating voltage = 60 KV, magnification = 200,000×).
Statistics. Mean and standard error were calculated for all the experiments using Microsoft Excel software (Microsoft Corporation).
Results
Bactericidal activity
A 15-minute incubation of vegetative bacteria with 10% 8N8 resulted in more than a 5-log reduction in the bac- 
Virucidal activity
Treatment of the Herpes simplex and influenza A viruses with 1% 8N8 for 15 minutes resulted in a 6-log reduction in pfu (Figure 2 ). Electronmicrographs of the influenza A virus treated with 1% 8N8 for 15 minutes showed only a few recognizable virions missing the viral envelope (Figure 4 B) , and 1 hour treatment resulted in complete disintegration of the virions (data not shown). The vaccinia virus was less susceptible to treatment with nanoemulsion. A time course showed that 10% 8N8 treatment required 30 minutes to achieve approximately a 5 log reduction ( Figure 3 ). As expected, non-enveloped adenovirus was completely resistant to 10% 8N8 treatment for 30 minutes, as examined using the β-galactosidase enzyme assay (data not shown). In electronmicrographs, the adenovirus structure remained unchanged even after 1 hour of treatment with 1% 8N8 ( Figure 4D ).
Fungistatic activity
Treatment of C. albicans with 8N8 at concentrations up to 50% did not have a direct fungicidal activity. However, 8N8 had a strong effect on the growth rate of C. albicans. As little as 1% nanoemulsion inhibited the growth of yeast by more than 92%, as compared to the growth rate of untreated yeast (data not shown). 
Discussion
There is an ongoing need for new antimicrobials to combat the continuous development of resistant microbes due to inappropriate use of antibiotics in humans and animals and the emergence of new microbes (Morse 1995 ; Rao 1998 ; Riley 1993 ; Tenover and Hughes 1996) . Surfactant nanoemulsions are one of the options. In this study, we showed that the novel surfactant nanoemulsion designated 8N8 has the potential to be used as a topical antimicrobial agent against several pathogens. 8N8 was bactericidal against vegetative forms of most Gram-positive bacteria including ; B. cereus, B. subtilis, S. pneumoniae, and S. pyogenes. S. aureus was an exception, being resistant even to 10% 8N8. Under our testing conditions few Gram-negative bacteria, including H. influenzae, N. gonorrhoeae and V. cholerae, were sensitive to 8N8 treatment. However, P. aeruginosa and enteric Gram-negative bacilli such as: C. freundii, E. coli, E. cloacae, P. mirabilis, S. typhimurium, and S. dysenterae were resistant to 10% 8N8. The resistance of the enteric Gram-negative bacilli may be attributable to its cell wall lipopolysaccharide (LPS) (Vaara 1993) and their negative surface charge. 8N8 also has a negative charge that may results in repulsive forces that prevent the nanoemulsion's attachment to the bacterial cell wall . However, it is likely that more than a single mechanism is involved in the resistance of bacteria to the emulsion since some Grampositive bacteria such as S. aureus were also found to be resistant to 8N8 treatment. All the tested enveloped viruses (Herpes simplex, influenza A and vaccinia) were sensitive to 8N8 treatment to different extents. Additionally, it has been reported that 8N8 is also virucidal to the HIV virus (Chatlynne et al. 1996) . This consistent inactivation of enveloped viruses suggests that 8N8 may affect the viral lipid membrane. This is further supported by the fact that nonenveloped viruses, such as adenovirus, are resistant to 8N8 treatment.
Although Candida albicans was completely resistant to the cidal effect of 8N8, it was unable to multiply in the presence of 1% 8N8. The resistance of yeast cells to the cidal effects of the nanoemulsions is most likely due to the rigid cell wall structure in yeast (Cassone 1986 ; Hiom et al. 1996) , which prevents 8N8 penetration. The fungistatic mechanism may be due to 8N8's disruption of the budding process by lysing newly formed yeast buds.
Previous toxicity studies showed that 8N8 administered at 10% concentration intramuscularly, subcutaneously or orally, and at 2% concentration intranasally was nontoxic to animals (Hamouda et al. 1999) . The fact that at lower concentrations 8N8 maintains its effective biocidal activity reveals its potential applications as a topical barrier against a wide range of microorganisms including bacteria, viruses and fungi compared to traditional antimicrobial agents which have selective activity. It will not be useful against some bacteria e.g. Staphylococcus and Pseudomonas or non-enveloped viruses. 8N8 is also effective against several sexually transmitted diseases (STD) including N. gonorrhoeae, HSV-2, and HIV, it could have a potential application for preventing these infections as well. Using 8N8 for the treatment of genital infection may also prevent yeast superinfection due to its fungistatic action. Further investigations are required to confirm the efficacy and safety of the use of 8N8 in a variety of human applications.
In conclusion, antimicrobial nanoemulsions are nonphospholipid-based, inexpensive, stable, non-toxic and non-specific antimicrobial agents that have potential clinical applications. Efforts are now being undertaken to produce formulations with broader biocidal spectra and a higher therapeutic index.
